179 related articles for article (PubMed ID: 34101502)
1. Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids.
Wallace K; Stewart EA; Wise LA; Nicholson WK; Parry JP; Zhang S; Laughlin-Tommaso S; Jacoby V; Anchan RM; Diamond MP; Venable S; Shiflett A; Wegienka GR; Maxwell GL; Wojdyla D; Myers ER; Marsh E
J Womens Health (Larchmt); 2022 Mar; 31(3):415-424. PubMed ID: 34101502
[No Abstract] [Full Text] [Related]
2. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
4. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
[No Abstract] [Full Text] [Related]
6. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey.
Soliman AM; Margolis MK; Castelli-Haley J; Fuldeore MJ; Owens CD; Coyne KS
Curr Med Res Opin; 2017 Nov; 33(11):1971-1978. PubMed ID: 28836862
[TBL] [Abstract][Full Text] [Related]
7. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
8. Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language.
Oliveira Brito LG; Malzone-Lott DA; Sandoval Fagundes MF; Magnani PS; Fernandes Arouca MA; Poli-Neto OB; Nogueira AA
Sao Paulo Med J; 2017; 135(2):107-115. PubMed ID: 28301630
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
[TBL] [Abstract][Full Text] [Related]
10. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
Harding G; Coyne KS; Thompson CL; Spies JB
Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
[TBL] [Abstract][Full Text] [Related]
11. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
12. Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study.
Keizer AL; van Kesteren PJM; Terwee C; de Lange ME; Hehenkamp WJK; Kok HS
BMJ Open; 2021 Nov; 11(11):e052664. PubMed ID: 34815284
[TBL] [Abstract][Full Text] [Related]
13. Burden of symptomatic uterine fibroids in Canadian women: a cohort study.
Laberge PY; Vilos GA; Vilos AG; Janiszewski PM
Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364
[TBL] [Abstract][Full Text] [Related]
14. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.
Venturella R; Lukes AS; Wu R; McLean R; Rakov VG; Al-Hendy A
Int J Gynaecol Obstet; 2024 May; 165(2):431-441. PubMed ID: 38576220
[TBL] [Abstract][Full Text] [Related]
15. Black Women Are More Likely Than White Women to Schedule a Uterine-Sparing Treatment for Leiomyomas.
Wegienka G; Stewart EA; Nicholson WK; Zhang S; Li F; Thomas L; Spies JB; Venable S; Laughlin-Tommaso S; Diamond MP; Anchan RM; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
J Womens Health (Larchmt); 2021 Mar; 30(3):355-366. PubMed ID: 33524308
[No Abstract] [Full Text] [Related]
16. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
17. Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL).
Coyne KS; Harrington A; Currie BM; Chen J; Gillard P; Spies JB
J Patient Rep Outcomes; 2019 Aug; 3(1):57. PubMed ID: 31444600
[TBL] [Abstract][Full Text] [Related]
18. Twelve-month outcomes for patients undergoing hysteroscopic morcellation of uterine polyps and myomas in an office or ambulatory surgical center.
Rubino RJ; Lukes AS
J Minim Invasive Gynecol; 2015 Feb; 22(2):285-90. PubMed ID: 25446547
[TBL] [Abstract][Full Text] [Related]
19. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
[TBL] [Abstract][Full Text] [Related]
20. The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
Keizer AL; Jacobs BL; Thurkow AL; de Lange ME; Radder CM; van Kesteren PJM; Hanstede MMF; Huirne JAF; Hehenkamp WJK
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():128-135. PubMed ID: 35640441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
